Enhanced etoposide sensitivity following adenovirus-mediated human topoisomerase IIα gene transfer is independent of topoisomerase IIβ

British Journal of Cancer

Volumn 85, Issue 5, 2001, Pages 747-751

  Zhou, Z ^a   Zwelling, L A ^a   Ganapathi, R ^b   Kleinerman, E S ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Amsacrine; Drug targetting; Etoposide; Topoisomerase II ; Topoisomerase II

Indexed keywords

AMSACRINE; DNA TOPOISOMERASE (ATP HYDROLYSING); ETOPOSIDE; ISOENZYME; TOPOISOMERASE IIALPHA; TOPOISOMERASE IIBETA; UNCLASSIFIED DRUG; VIRUS VECTOR;

ADENOVIRUS; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL; CONTROLLED STUDY; DRUG SENSITIVITY; GENE EXPRESSION; GENE TRANSFER; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL;

ADENOVIRIDAE; AMSACRINE; ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DNA TOPOISOMERASES, TYPE II; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; DNA-BINDING PROTEINS; DRUG RESISTANCE, NEOPLASM; ETOPOSIDE; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; ISOENZYMES; TUMOR CELLS, CULTURED;

EID: 0035445584     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2001.1966     Document Type: Article

References (21)

1. Transfection of human topoisomerase IIα gene into etoposide-resistant cells: Transient increase in sensitivity followed by down-regulation of the endogenous gene
2. Transfection of a human topoisomerase 11α gene into etoposide-resistant human breast tumor cells sensitizes the cell to etoposide
3. Eukaryotic DNA topoisomerase IIβ
4. Novel Hela topoisomerase is the IIβ isoform: Complete coding sequence and homology with other type II topoisomerases
5. Role of topoisomerase II beta in the resistance of 9-OH-ellipticine-resistant Chinese hamster fibroblast to topoisomerase II inhibitors
6. Murine transgenic cells lacking DNA topoisomerase IIb are resistant to Acridines and Mitoxantrone: Analysis of cytotoxicity and cleavable complex formation
7. Circumvention of multidrug resistance in murine fibrosarcoma and colon carcinoma cells by treatment with the α-adrenoceptor antagonist furobenzepine
8. Resistance to etoposide in human leukemia HL-60 cells: Reduction in drug-induced DNA cleavage associated with hypophosphorylation of topoisomerase II phosphopeptides
9. Absence of topoisomerase IIβ in an amsacrine-resistant human leukemia cell line with mutant topoisomerase IIα
10. Isolation of cDNA clones encoding the β isozyme of human DNA topoisomerase II and localization of the gene to chromosome 3q24
11. The ras omcogene-mediated sensitization of human cells to toposiomerase II inhibitor-induced apoptosis
12. DNA topoisomerase targeting drugs: Mechanism of action and perspectives
13. Cellular adaptation to drug exposure: Evolution of the drug-resistant phenotype
14. Topoisomerase IIα and topoisomerase IIβ genes: Characterization and mapping to human chromosome 17 and 3, respectively
15. Cloning and sequencing of cDNA encoding human DNA topoisomerase II and localization of the gene to chromosome region 17q21-22
16. The distribution and expression of the two isoforms of DNA topoisomerase II in normal and neoplastic human tissues
17. DNA topoisomerase
18. 4
19. DNA topoisomerase IIβ and neural development
20. Characterization of an amsacrine-resistant line of human leukemia cells
21. Adenovirus-mediated human topoisomerase IIα gene transfer increases the sensitivity of etoposide-resistant human breast cancer cells